4.8 Article

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions

期刊

CIRCULATION
卷 124, 期 23, 页码 E574-E651

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIR.0b013e31823ba622

关键词

AHA Scientific Statements; acute coronary syndromes; anticoagulants; antiplatelet agents; antiplatelet agents; arrhythmias, cardiac; coronary artery revascularization interventions: stents; coronary angiography; drug therapy; drug delivery systems; heart diseases; myocardial revascularization; platelet aggregation inhibitor; ultrasound

向作者/读者索取更多资源

The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When properly applied, expert analysis of available data on the benefits and risks of these therapies and procedures can improve the quality of care, optimize patient outcomes, and favorably affect costs by focusing resources on the most effective strategies. An organized and directed approach to a thorough review of evidence has resulted in the production of clinical practice guidelines that assist physicians in selecting the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据